Baseline serum and tumor TAG-72 levels from trial C-9701
| Patient ID | Tumor TAG-72 (% positive) | Tumor TAG-72 Intensity | Serum TAG-72 (U/mL) |
|---|---|---|---|
| 201A | 5 | 2+ | 9.4 |
| 202B | 60 | 2+ | 7.3 |
| 203C | 95 | 2+ | 91.3 |
| 204D | 5 | 1+ | 4.1 |
| 205E | 80 | 2+ | 8.2 |
| 206K | 60 | 2+ | 293.5 |
| 207L | 70 | 2+ | NA |
| 101F | 10 | 2+ | 148.3 |
| 102G | 5 | 1+ | 6.4 |
| 103H | 5 | 1+ | 96.9 |
| 104I | 5 | 1+ | 13.6 |
| 105J | 25 | 2+ | 19.8 |
| 106M | 80 | 2+ | 187.4 |
| 107N | 50 | 2+ | NA |
NA not available
Tumor TAG-72 levels were measured in archival or fresh tumors at baseline by immunohistochemistry and quantified as percentage of cells staining positive and staining intensity. Serum TAG-72 levels were measured using a CC49 capture radio-immunoassay